Search results for "Ulcerative"

showing 10 items of 294 documents

P658 The Inflammatory Bowel Disease Disability Index (IBD-DI) in ulcerative colitis is related to disease activity, need of immunosuppressive therapy…

2017

medicine.medical_specialtybusiness.industryGastroenterologyGeneral Medicinemedicine.diseaseUlcerative colitisGastroenterologyInflammatory bowel diseaseDisease activityTherapeutic immunosuppression03 medical and health sciences0302 clinical medicineQuality of lifeInternal medicinemedicine030211 gastroenterology & hepatology030212 general & internal medicinebusinessJournal of Crohn's and Colitis
researchProduct

Multifocal Pyoderma Gangrenosum Resistant to Infliximab in Active Ulcerative Colitis: Donʼt Forget the Role of Cyclosporin

2012

medicine.medical_specialtybusiness.industryGastroenterologymedicineImmunology and Allergymedicine.diseasebusinessUlcerative colitisDermatologyPyoderma gangrenosumInfliximabmedicine.drugInflammatory Bowel Diseases
researchProduct

Cytomegalovirus disappearance after treatment for refractory ulcerative colitis in 2 patients treated with infliximab and 1 patient with leukapheresis

2009

medicine.medical_specialtybusiness.industryIBDGastroenterologyCongenital cytomegalovirus infectionCytomegaloviruLeukapheresismedicine.diseaseGastroenterologyUlcerative colitisInfliximabRefractoryInternal medicineImmunology and AllergyMedicineColitisbusinessAfter treatmentmedicine.drug
researchProduct

Use of Calprest ® in the diagnosis of Inflammatory Bowel Disease (IBD)

2002

Abstract Background: Between November 2000 and February 2001 a study has been performed by eight Italian hospital centers with the aim of verifying the usefulness of Calprest® (detection of fecal calprotectin) as a marker of bowel inflammation. Preliminary data are reported. Objective: To define the use of fecal calprotectin as a marker of intestinal inflammation, to assess whether it might help in differentiating between IBS and IBD, and its role in IBD. Subjects: Healthy population (51), active Crohn (16), non active or under remission Crohn (11), active ulcerative Colitis (8), non active or under remission ulcerative Colitis (13), pathological Controls of various nature (79). Results: Th…

medicine.medical_specialtybusiness.industryImmunologyInflammationmedicine.diseaseNegative Test ResultMicrobiologyGastroenterologyInflammatory bowel diseaseUlcerative colitisdigestive system diseasesInfectious DiseasesIntestinal inflammationInternal medicineImmunologyImmunology and AllergyMedicineCalprotectinmedicine.symptombusinessPathologicalFecesClinical and Applied Immunology Reviews
researchProduct

P611 Outcome in ulcerative colitis after switch from subcutaneous anti-TNF to intravenous anti-TNF: A multicentre study

2018

medicine.medical_specialtybusiness.industryInternal medicineGastroenterologyMedicineTumor necrosis factor alphaGeneral Medicinebusinessmedicine.diseaseUlcerative colitisGastroenterologyJournal of Crohn's and Colitis
researchProduct

Chromoendoscopy: An Evolving Standard in Surveillance for Ulcerative Colitis

2004

medicine.medical_specialtybusiness.industryInternal medicineGastroenterologymedicineImmunology and Allergybusinessmedicine.diseaseGastroenterologyUlcerative colitisChromoendoscopyInflammatory Bowel Diseases
researchProduct

Ulcerative colitis - How can we improve surveillance colonoscopy?

2003

medicine.medical_specialtybusiness.industryInternal medicinemedicineGeneral Medicinemedicine.diseasebusinessUlcerative colitisGastroenterologyDMW - Deutsche Medizinische Wochenschrift
researchProduct

Therapeutic Potential of the Gabaergic System in Ulcerative Colitis: Current Status and Perspectives

2017

This concise commentary deals with the manuscript, in the issue 10, volume 32 of Digestive Diseases and Sciences 2017, by Aggarwal et al. which provides data supporting the contribution of GABA and GABAergic signalling to the pathogenesis of ulcerative colitis (UC) in humans

medicine.medical_specialtybusiness.industryPhysiologyGastroenterologyHepatologymedicine.diseaseUlcerative colitisGastroenterologySettore BIO/09 - FisiologiaTransplant surgeryInternal medicinemedicineGABAergicHumansColitis Ulcerativebusiness
researchProduct

Leukocytapheresis in patients with moderate-severe steroid-dependant ulcerative colitis: Clinical Response without Endoscopic Response

2006

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentGastroenterology.medicine.diseaseGastroenterologyUlcerative colitisSteroidInternal medicinemedicineImmunology and AllergyIn patientDependantbusinessInflammatory Bowel Diseases
researchProduct

Surveillance colonoscopy in ulcerative colitis: magnifying chromoendoscopy in the spotlight

2004

Chromoendoscopy in ulcerative colitis may offer the possibility of detecting dysplastic or neoplastic changes at a curable stage, and thus expand the indication for chromoendoscopy from screening to surveillance colonoscopy Colonoscopy is the gold standard for colorectal cancer screening.1–3 Detection and complete removal of adenomas disrupt the adenoma-carcinoma sequence and thus prevent the development of colorectal cancer. However, endoscopists still fear that they may have overlooked relevant lesions despite the availability of modern videoendoscopes. This problem is underlined by a relatively high rate of adenomas missed by conventional endoscopy (up to 27%), as determined by back to b…

medicine.medical_specialtymedicine.diagnostic_testAdenomabusiness.industryColorectal cancerGastroenterologyColonoscopymedicine.diseaseGastroenterologyUlcerative colitisdigestive system diseasesChromoendoscopyFlat AdenomaIntestinal mucosaInternal medicineCommentaryMedicinebusinessMass screening
researchProduct